Insulin resistance has been explained by inhibition of GLUT-4 [48], although changes in carbohydrate metabolism appear to be mediated by lipohypertrophy [49], lipoatrophy, and dyslipidemias due to mitochondrial toxicity in the liver and muscles [47]. Here, SLC2A4 is linked to metabolic syndrome.